A detailed history of Sei Investments CO transactions in Pfizer Inc stock. As of the latest transaction made, Sei Investments CO holds 1,660,724 shares of PFE stock, worth $46.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,660,724
Previous 1,534,251 8.24%
Holding current value
$46.5 Million
Previous $44.2 Million 4.33%
% of portfolio
0.07%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $3.27 Million - $3.76 Million
126,473 Added 8.24%
1,660,724 $46.1 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $307,994 - $400,050
-11,787 Reduced 0.76%
1,534,251 $44.2 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2.11 Million - $2.46 Million
-65,634 Reduced 4.07%
1,546,038 $51.3 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $1.34 Million - $1.55 Million
-37,096 Reduced 2.25%
1,611,672 $59.1 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $24.1 Million - $31.4 Million
612,029 Added 59.03%
1,648,768 $67.3 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $14.1 Million - $18.4 Million
-336,933 Reduced 24.53%
1,036,739 $53.1 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $514,967 - $628,646
11,768 Added 0.86%
1,373,672 $60.1 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $18.4 Million - $21.8 Million
395,783 Added 40.97%
1,361,904 $71.5 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $8.31 Million - $10.3 Million
-181,644 Reduced 15.83%
966,121 $50 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $1.49 Million - $2.2 Million
35,958 Added 3.23%
1,147,765 $67.8 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $542,435 - $696,804
13,820 Added 1.26%
1,111,807 $47.8 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $10.9 Million - $12.3 Million
303,155 Added 38.14%
1,097,987 $43 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $1.02 Million - $1.15 Million
-30,349 Reduced 3.68%
794,832 $29.1 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $16.1 Million - $20.4 Million
-480,270 Reduced 36.79%
825,181 $30.4 Million
Q3 2020

Dec 04, 2020

SELL
$31.75 - $37.25 $3.11 Million - $3.65 Million
-97,864 Reduced 6.97%
1,305,451 $47.9 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $618,902 - $726,114
-19,493 Reduced 1.37%
1,403,315 $51.5 Million
Q2 2020

Aug 17, 2020

SELL
$30.12 - $36.54 $9.29 Million - $11.3 Million
-308,274 Reduced 17.81%
1,422,808 $46.5 Million
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $6.95 Million - $8.43 Million
230,718 Added 15.38%
1,731,082 $63.3 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $3.64 Million - $5.2 Million
-134,564 Reduced 8.23%
1,500,364 $49 Million
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $1.67 Million - $1.9 Million
-50,737 Reduced 3.01%
1,634,928 $64 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $129,050 - $167,340
3,972 Added 0.24%
1,685,665 $60.6 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $1.24 Million - $1.4 Million
33,624 Added 2.04%
1,681,693 $73 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $3.12 Million - $3.42 Million
-83,076 Reduced 4.8%
1,648,069 $70.1 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $11.8 Million - $13.4 Million
305,769 Added 21.45%
1,731,145 $76.1 Million
Q3 2018

Nov 08, 2018

SELL
$34.47 - $41.81 $30.4 Million - $36.9 Million
-883,039 Reduced 38.25%
1,425,376 $62.9 Million
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $7.69 Million - $8.2 Million
-233,190 Reduced 9.17%
2,308,415 $83.8 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $929,442 - $1.08 Million
29,127 Added 1.16%
2,541,605 $90.2 Million
Q4 2017

Feb 08, 2018

BUY
$33.26 - $35.29 $12.8 Million - $13.6 Million
386,069 Added 18.16%
2,512,478 $91 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $65.9 Million - $72.6 Million
2,126,409
2,126,409 $75.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.